About
Mark Gallop is a medicinal chemist and serial biotech entrepreneur best known as co-founder and chairman of Rubedo Life Sciences and co-founder of XenoPort. He has also held senior scientific and advisory roles at Nurix, BlueLight Therapeutics, Light Horse Therapeutics, and 5AM Ventures-adjacent company creation efforts. His public profile centers on drug discovery, prodrug design, and translational biotech leadership rather than direct investing.
Areas of interest
longevitybiotechdrug discoverymedicinal chemistrycellular senescenceoncologyneurosciencegastrointestinal disordersprodrug designcomputational biologydermatologyaging biology